Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
Northwestern University
Northwestern University
University of Texas Southwestern Medical Center
University of Miami
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center